RHD Genotype Matched Red Cells for Anti-D

Clinical trial NCT04156906 · COMPLETED

Trial details

NCT number: NCT04156906
Sponsor: Children's Hospital of Philadelphia
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease Anti-D Antibodies

Start date: 2020-07-08
Primary completion: 2024-03-04
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.